Heme Iron Intake Linked to Increased Risk for Type 2 Diabetes
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 19, 2024 -- Heme iron intake is associated with an increased risk for type 2 diabetes (T2D), according to a study published online Aug. 13 in Nature Medicine.
Fenglei Wang, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues analyzed data from 204,615 participants in large U.S. cohorts during up to 36 years to examine the associations between iron intake and T2D risk. Plasma metabolic biomarkers and metabolomics profiles were assessed in subsets of 37,544 and 9,024 participants, respectively.
The researchers observed an association between heme iron intake, but not non-heme iron intake, and an increased risk for T2D, with a multivariable-adjusted hazard ratio of 1.26 comparing the highest versus the lowest quintiles. Significant proportions of the T2D link with unprocessed red meat and specific dietary patterns were accounted for by heme iron. Correlations were seen for increased heme iron intake with unfavorable plasma profiles of insulinemia, lipids, inflammation, and T2D-linked metabolites. Metabolites such as L-valine and uric acid potentially mediate the relationship between heme iron and T2D.
"These findings have important public health implications in shaping guidelines to prevent diabetes by limiting the daily consumption of foods rich in heme iron, particularly red meat," the authors write. "They also raise concerns about adding plant-derived heme to plant-based meat alternatives."
One author disclosed financial ties to Vinasoy.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials
THURSDAY, June 12, 2025 -- For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent on average, which is lower...
Increasing Proportion of U.S. Adults Unaware They Have Hypertension
MONDAY, June 9, 2025 -- From 2013 to 2023, there was an increase in the proportion of U.S. adults who were unaware of having hypertension, according to a research letter published...
Finerenone + Empagliflozin Offers Greater Benefit in CKD, T2DM
MONDAY, June 9, 2025 -- For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater reduction in the urinary...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.